Scientists discover that the CD74 protein could predict the effectiveness of immunotherapy, advancing colon cancer treatment.
Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...
Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback